Search: 2017 EU Meeting Faculty
Results 1 - 4 of 4

Rachel Jones

Patient Engagement Consultant
admedicum Business for Patients GmbH & Co KG

Bio: Rachel Jones started her career as a Community Pharmacist in the UK Healthcare system and she quickly realised that her role was most valuable when she equipped people with the information and tools to understand their own health and the medicines that were needed as part of their care. In her most recent role within AstraZeneca, Rachel has been charged with inputting the patient centric strategy as a Global, companywide initiative. One of her key land mark projects has been to facilitate a consumer charter for the company which was led by patients and their families to add insight and direction to the way in which a large corporate body conducts its business. She is also mid way through her masters in Behavioural Change and is the senior author on a peer reviewed manuscript which was published in the BMJ in 2016 in relation to patient centricity.

Nina C Kennard

Head of Cello Health MedErgy, Medical Affairs
Cello Health MedErgy

Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP
CMPP Certified: (9/2015)

Bio: Nina has led the medical affairs and publications teams within iS LifeScience for the last 5 years and is now the Head of iS LifeScience, a Cello Health business. Nina has 15 years of experience of strategic publication planning and delivery, gained from both medical communication agencies and pharma. She passed her CMPP in 2015 and provides strategic input and consultancy on publication guidelines and best-practice policy to her clients. Nina is a patient reviewer for the BMJ and passionately believes in patient-focussed healthcare. She actively encourages the medical community to better understand patient pathways and to bring a stronger patient voice to medical publications and communications. One of next years (2017) abstracts/oral presentations submitted to the ISMPP EU meeting from the Cello Health team raises questions about the value of patient-centric market research in defining clinical outcomes and best practice care for patients. Nina comes from a strong scientific and medical writing background and has successfully led both small and large publication teams in European and global capacities. She has worked across a wealth of therapeutic areas in pharmaceuticals, medical devices and medical diagnostics. During her 6 years in-house at Abbott, Nina led an R&D team, worked across a number of therapy areas, and wrote trial proposals, study reports and publications for different audiences.

Kay Koyander

Global Publications Leader, Global Medical Affairs

Type of Company:
Professional Degrees: BA/BS
CMPP Certified: 3/2015

Paul Lane

Associate Director Medical Communications
Biomarin Pharmaceutical Inc

Type of Company:
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2010)

Bio: Paul conducted his Doctoral research into the physiological roles of nitric oxide at Weill Medical College of Cornell University. After serving on the faculty at Weill, Paul worked as a freelance consultant specializing in start-up grants for biotechnology companies, before transitioning full-time to medical publications. He has been a publications professional for over 10 years and has worked on programs spanning all stages of drug development in a variety of therapeutic areas. Until recently, Paul was responsible for Digital and Social Media strategy at Envision Pharma Group, but has now moved on to run publication programs for various rare diseases at Biomarin. The shift from print to web-based publications has been an area of interest since Paul authored a review in one of the first online journals (Science:STKE) in 2001. Much has changed since then, with journals and congresses now offering a plethora of enhancements and the rise of social media as a channel for information dissemination. These additions not only change the way in which medical information is consumed, but also the methods we use to assess the impact of a publication.